Apollomics (APLM) Current Leases (2021 - 2025)

Apollomics (APLM) reported Current Leases of $209000.0 for Q4 2025, down 65.96% quarter-over-quarter from $614000.0 in Q4 2022.

Apollomics (APLM) Current Leases (2021 - 2025) Analysis & Trends

Apollomics (APLM) has 3 years of Current Leases data on file, last reported at $209000.0 in Q4 2025.

  • Current Leases for Q4 2025 came in at $209000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $209000.0 (changed N/A YoY), and the FY2025 annual result was $209000.0, changed N/A from the prior year.
  • Current Leases slipped to $209000.0 in Q4 2025 per APLM's latest filing, from $614000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $614000.0 in Q4 2022 and troughed at $209000.0 in Q4 2025.
  • A 3-year average of $443666.7 and a median of $508000.0 in 2021 frame the typical range for Current Leases.
  • On a YoY basis, Current Leases climbed as much as 20.87% in 2022 and fell as far as 20.87% in 2022.
  • A 3-year view of Current Leases shows it stood at $508000.0 in 2021, then advanced by 20.87% to $614000.0 in 2022, then slumped by 65.96% to $209000.0 in 2025.
  • Business Quant data shows APLM's Current Leases at $209000.0 in Q4 2025, $614000.0 in Q4 2022, and $508000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 42,980.09
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 83,991.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 7.40 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Apollomics 294.00 Mn 294.00 Mn - 209,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 209,000.00
Dec 31, 2022 614,000.00
Dec 31, 2021 508,000.00